Where is gainsharing?
This article was originally published in The Gray Sheet
CMS signals further delays to a gainsharing demonstration program mandated under the Deficit Reduction Act of 2005 with a July 5 solicitation for more applicants. A "limited response from rural hospitals" to the original solicitation in September prompted a 1notice in the Federal Register asking more rural hospitals to submit proposals for sharing payments between physicians and hospitals to improve quality and efficiency of care. The demo, originally slated to begin in January 2007, will take place at six hospitals, two of which must be rural (2"The Gray Sheet" Sept. 25, 2006, p. 12). New applications are due Sept. 4. A second CMS demonstration program authorized under the Medicare Modernization Act "is a little bit further behind," said Acting Deputy Administrator Herb Kuhn in May...
You may also be interested in...
Manufacturers of endoscopic equipment, biofeedback devices and thermometers were among those cited for regulatory violations in US FDA warning letters this week. A total of four device-related enforcement missives were released by the agency.
The biopharma industry has struggled to recruit patients into clinical trials that adequately reflect the diverse patient populations they hope to reach with new products. Failure to improve minority subgroup participation now will cost trial sponsors later.
A flurry of US biosimilar launches over the past few months has opened several molecules to true, multi-source competition, with a range of pricing strategies seen from competitors. However, some brands that already face biosimilar competition elsewhere in the world are still poised to enjoy a significant period of exclusivity in the US, such as AbbVie’s Humira.